Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

311 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of lisinopril for mild childhood IgA nephropathy: a pilot study.
Nakanishi K, Iijima K, Ishikura K, Hataya H, Awazu M, Sako M, Honda M, Yoshikawa N; Japanese Pediatric IgA Nephropathy Treatment Study Group. Nakanishi K, et al. Among authors: ishikura k. Pediatr Nephrol. 2009 Apr;24(4):845-9. doi: 10.1007/s00467-008-1006-8. Epub 2008 Sep 30. Pediatr Nephrol. 2009. PMID: 18825420 Clinical Trial.
Cyclosporine and steroid therapy in children with steroid-resistant nephrotic syndrome.
Hamasaki Y, Yoshikawa N, Hattori S, Sasaki S, Iijima K, Nakanishi K, Matsuyama T, Ishikura K, Yata N, Kaneko T, Honda M; Japanese Study Group of Renal Disease. Hamasaki Y, et al. Among authors: ishikura k. Pediatr Nephrol. 2009 Nov;24(11):2177-85. doi: 10.1007/s00467-009-1264-0. Pediatr Nephrol. 2009. PMID: 19714370 Clinical Trial.
Prospective 5-year follow-up of cyclosporine treatment in children with steroid-resistant nephrosis.
Hamasaki Y, Yoshikawa N, Nakazato H, Sasaki S, Iijima K, Nakanishi K, Matsuyama T, Ishikura K, Ito S, Kaneko T, Honda M; for Japanese Study Group of Renal Disease in Children. Hamasaki Y, et al. Among authors: ishikura k. Pediatr Nephrol. 2013 May;28(5):765-71. doi: 10.1007/s00467-012-2393-4. Epub 2013 Jan 13. Pediatr Nephrol. 2013. PMID: 23314441 Clinical Trial.
Two-year outcome of the ISKDC regimen and frequent-relapsing risk in children with idiopathic nephrotic syndrome.
Nakanishi K, Iijima K, Ishikura K, Hataya H, Nakazato H, Sasaki S, Honda M, Yoshikawa N; Japanese Study Group of Renal Disease in Children. Nakanishi K, et al. Among authors: ishikura k. Clin J Am Soc Nephrol. 2013 May;8(5):756-62. doi: 10.2215/CJN.09010912. Epub 2013 Jan 31. Clin J Am Soc Nephrol. 2013. PMID: 23371961 Free PMC article. Clinical Trial.
Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial.
Iijima K, Sako M, Nozu K, Mori R, Tuchida N, Kamei K, Miura K, Aya K, Nakanishi K, Ohtomo Y, Takahashi S, Tanaka R, Kaito H, Nakamura H, Ishikura K, Ito S, Ohashi Y; Rituximab for Childhood-onset Refractory Nephrotic Syndrome (RCRNS) Study Group. Iijima K, et al. Among authors: ishikura k. Lancet. 2014 Oct 4;384(9950):1273-81. doi: 10.1016/S0140-6736(14)60541-9. Epub 2014 Jun 22. Lancet. 2014. PMID: 24965823 Clinical Trial.
A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment.
Yoshikawa N, Nakanishi K, Sako M, Oba MS, Mori R, Ota E, Ishikura K, Hataya H, Honda M, Ito S, Shima Y, Kaito H, Nozu K, Nakamura H, Igarashi T, Ohashi Y, Iijima K; Japanese Study Group of Kidney Disease in Children. Yoshikawa N, et al. Among authors: ishikura k. Kidney Int. 2015 Jan;87(1):225-32. doi: 10.1038/ki.2014.260. Epub 2014 Jul 23. Kidney Int. 2015. PMID: 25054775 Free PMC article. Clinical Trial.
311 results